On April 30, 2025, 180 Life Sciences Corp. announced it had entered into a Settlement and Mutual Release Agreement with Elray Resources, Inc. and Luxor Capital, LLC. This agreement includes a significant repurchase of shares.
The company stated that this agreement strengthens and simplifies its capital structure. Resolving disputes and repurchasing shares can reduce uncertainty and improve financial clarity.
This move is part of the company's broader efforts to optimize its financial position as it continues its strategic transformation. The specific details of the share repurchase were not immediately disclosed beyond its significance to the capital structure.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.